Search

Your search keyword '"Fei, Keke"' showing total 8 results
Start Over Author "Fei, Keke"
8 results on '"Fei, Keke"'

3. IBI379, a novel B cell maturation antigen/CD3 bispecific T-cell engager, displays high antitumor efficacy in preclinical models of multiple myeloma

Author

Fei, Keke, primary, Ni, Haiqing, additional, Zhu, Mengjia, additional, Kuang, Zhihui, additional, Wu, Min, additional, Wu, Zhihai, additional, Wang, Feifei, additional, Zhou, Shuaixiang, additional, Jing, Hua, additional, Wu, Weiwei, additional, Wu, Dongdong, additional, Bai, Dongmei, additional, and Chen, Bingliang, additional

Published
2022
Full Text
View/download PDF

7. Durable blockade of PD-1 signaling links preclinical efficacy of sintilimab to its clinical benefit

Author

Wang, Jie, primary, Fei, Keke, additional, Jing, Hua, additional, Wu, Zhihai, additional, Wu, Weiwei, additional, Zhou, Shuaixiang, additional, Ni, Haiqing, additional, Chen, Bingliang, additional, Xiong, Yan, additional, Liu, Yanpeng, additional, Peng, Bo, additional, Yu, Dechao, additional, Jiang, Haiping, additional, and Liu, Junjian, additional

Published
2019
Full Text
View/download PDF

8. LcrQ Coordinates with the YopD-LcrH Complex To Repress lcrFExpression and Control Type III Secretion by Yersinia pseudotuberculosis

Author

Fei, Keke, Yan, Huan, Zeng, Xiaoyan, Huang, Shaojia, Tang, Wei, Francis, Matthew S., Chen, Shiyun, and Hu, Yangbo

Abstract

All three human-pathogenic Yesiniaspecies, Y. pestis, Y. enterocolitica, and Y. pseudotuberculosis, employ a plasmid-encoded T3SS to target immunomodulatory effectors into host immune cells. Several plasmid-encoded regulators influence T3SS control, including the master transcriptional activator LcrF, the posttranscriptional repressor YopD, and the unassigned negative regulatory factor LcrQ.

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results